STIP1 and ovarian carcinoma: Because borderline ovarian tumors are generally characterized by a good prognosis and are not commonly included in ovarian cancer clinical trials, the independent prognostic significance of STIP1 levels was analyzed only in the subgroup of patients with invasive ovarian cancer (n = 280).